HSBC kicks off Singapore insurance business sale, eyes over $1 billion value, sources say

Core Viewpoint - HSBC has initiated the sale process for its Singapore life insurance product manufacturing business, aiming for a valuation exceeding $1 billion, with JPMorgan acting as its adviser [1][2]. Group 1: Sale Process - HSBC has begun engaging with potential buyers, including Japanese insurers Nippon Life and Dai-ichi Life, with non-binding bids expected within a month [2]. - The bank's decision to sell is part of its strategy to focus on its core operations in Asia, where it generates the majority of its revenues and profits [1]. Group 2: Advisory Role - JPMorgan has been hired as the adviser for the sale process, indicating the significance of the transaction for HSBC [1]. - Both HSBC and JPMorgan have declined to comment on the potential sale, maintaining confidentiality around the negotiations [2].